發(fā)布時(shí)間：2018-05-31 07:55

  本文選題：吳茱萸 + 穴位貼敷��； 參考：《廣州中醫(yī)藥大學(xué)》2017年碩士論文

【摘要】：目的:本研究旨在研究吳茱萸貼敷足三里、內(nèi)關(guān)穴對胃腸道惡性腫瘤術(shù)后胃腸功能恢復(fù)的療效,為胃腸外科臨床應(yīng)用及推廣吳茱萸穴位貼敷促進(jìn)胃腸道惡性腫瘤術(shù)后胃腸功能恢復(fù)提供依據(jù),為臨床上針對術(shù)后胃腸功能恢復(fù)提供一種操作簡便、廉價(jià)且療效確切的中醫(yī)外治法,探索中醫(yī)藥在外科術(shù)后康復(fù)方面的應(yīng)用。方法:本研究采用隨機(jī)對照,將2015年3月至2017年2月入住我院二外科行胃腸道惡性腫瘤手術(shù)且中醫(yī)表現(xiàn)為氣滯血瘀、脾胃虛寒癥者為研究對象,通過隨機(jī)分配的方法將納入對象分為治療組和對照組。治療組術(shù)后給予西醫(yī)基礎(chǔ)治療及吳茱萸貼敷足三里、內(nèi)關(guān)穴治療;對照組術(shù)后僅給予西醫(yī)基礎(chǔ)治療。西醫(yī)基礎(chǔ)治療包括外科術(shù)后常規(guī)護(hù)理、術(shù)后禁食禁飲、胃腸減壓、抗生素預(yù)防感染、補(bǔ)液維持水電解質(zhì)酸堿平衡及腸外營養(yǎng)支持。自患者術(shù)后麻醉清醒后觀察兩組患者術(shù)后首次排氣、排便時(shí)間、給予全流時(shí)間及并發(fā)癥發(fā)生情況,收集臨床數(shù)據(jù),整理資料,最后進(jìn)行統(tǒng)計(jì)學(xué)分析得出結(jié)論。結(jié)果:1.對比兩組患者治療前的基線資料(包括性別、年齡、病種、手術(shù)方式、術(shù)中出血量及手術(shù)時(shí)間),差異并無統(tǒng)計(jì)學(xué)意義(P0.05),即兩組基線水平無明顯差異,兩組資料具備可比性;2.對比兩組觀察指標(biāo),經(jīng)統(tǒng)計(jì)學(xué)檢驗(yàn),治療組術(shù)后首次排氣、排便時(shí)間及全流時(shí)間較對照組更短,治療組療效優(yōu)于對照組。3.經(jīng)對比兩組患者術(shù)后并發(fā)癥發(fā)生情況,得出治療組治療方法并不會增加患者術(shù)后并發(fā)癥發(fā)生率,治療組治療方法安全性較高。4.經(jīng)統(tǒng)計(jì)學(xué)分析最后得出結(jié)論,治療組對促進(jìn)胃腸道惡性腫瘤術(shù)后胃腸功能恢復(fù)的療效優(yōu)于對照組,并具有較高安全性,該研究在臨床有應(yīng)用價(jià)值。結(jié)論:使用吳茱萸貼敷足三里、內(nèi)關(guān)穴能促進(jìn)胃腸道惡性腫瘤術(shù)后胃腸功能的早日恢復(fù),有助于中醫(yī)藥在外科術(shù)后康復(fù)方面的應(yīng)用。
[Abstract]:Objective: to study the effect of Evodia rutaecarpa applied on Zusanli and Neiguan points on gastrointestinal function recovery after operation of gastrointestinal malignant tumor. To provide a basis for the clinical application of gastroenteric surgery and to promote the recovery of gastrointestinal function after operation of gastrointestinal malignant tumor, and to provide a simple and convenient operation for the recovery of gastrointestinal function after operation. To explore the application of traditional Chinese medicine in postoperative rehabilitation. Methods: in this study, randomized control was used to study the patients who were admitted to our hospital from March 2015 to February 2017 to perform gastrointestinal cancer surgery with Qi stagnation and blood stasis and deficiency of spleen and stomach with cold syndrome in traditional Chinese medicine. The subjects were randomly divided into treatment group and control group. The treatment group was treated with basic western medicine and Evodia rutaecarpa with Zusanli and Neiguan points, while the control group was only treated with western medicine. The basic treatment of western medicine includes routine nursing after surgery, fasting and drinking, gastrointestinal decompression, antibiotic prevention of infection, rehydration to maintain water electrolyte acid-base balance and parenteral nutrition support. The first time of exhaust, defecation, the time of total flow and the occurrence of complications were observed. The clinical data were collected and the data were sorted out. Finally, the conclusion was obtained by statistical analysis. The result is 1: 1. The baseline data (including sex, age, disease, operative method, intraoperative bleeding volume and operation time) of the two groups before treatment were compared. The difference was not statistically significant (P 0.05), that is, there was no significant difference in baseline level between the two groups, and the data of the two groups were comparable. Compared with the two groups, after statistical test, the treatment group after the first exhaust, defecation time and total flow time is shorter than the control group, the treatment group is better than the control group. 3. By comparing the incidence of postoperative complications between the two groups, it was concluded that the treatment group did not increase the incidence of postoperative complications, and the safety of the treatment group was higher than that of the control group. 4. It was concluded by statistical analysis that the curative effect of the treatment group was superior to that of the control group in promoting the recovery of gastrointestinal function after operation of gastrointestinal malignant tumor. Conclusion: the application of Evodia rutaecarpa to Zusanli can promote the early recovery of gastrointestinal function after operation of gastrointestinal malignant tumor and is helpful to the application of traditional Chinese medicine in postoperative rehabilitation.
【學(xué)位授予單位】：廣州中醫(yī)藥大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：R735

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 秦愛玲;;艾灸足三里、神闕穴對剖宮產(chǎn)術(shù)后胃腸蠕動(dòng)功能恢復(fù)作用的臨床研究[J];甘肅中醫(yī)學(xué)院學(xué)報(bào);2014年05期

2 倪永妍;;足三里穴位注射促進(jìn)腹部手術(shù)后胃腸功能恢復(fù)淺談[J];甘肅科技縱橫;2014年02期

3 萬怡冰;朱桔;王曉利;顧伶俐;張曉菊;;咀嚼口香糖促進(jìn)胃癌患者術(shù)后胃腸功能1例循證實(shí)踐[J];上海護(hù)理;2014年01期

4 張兆莉;;耳穴埋豆對外科術(shù)后胃腸功能腹脹恢復(fù)的探討[J];中外醫(yī)學(xué)研究;2014年01期

5 張波;譚旭東;;足三里注射對腹腔鏡術(shù)后胃腸動(dòng)力的影響[J];世界中西醫(yī)結(jié)合雜志;2013年09期

6 張慧力;尚大可;高滿倉;;厚樸排氣合劑保留灌腸對腹部手術(shù)后胃腸功能恢復(fù)的研究[J];中國衛(wèi)生產(chǎn)業(yè);2013年23期

7 沈瑾;;四磨湯穴位貼敷促進(jìn)術(shù)后胃腸動(dòng)力恢復(fù)30例[J];江西中醫(yī)藥;2013年03期

8 胡冬青;曹志群;;穴位貼敷療法在消化系統(tǒng)疾病中的應(yīng)用[J];河南中醫(yī);2012年09期

9 王宇;陳莉;沐榕;;針刺治療術(shù)后腸麻痹療效觀察(英文)[J];World Journal of Acupuncture-Moxibustion;2011年04期

10 袁超;;胃癌術(shù)后早期腸內(nèi)營養(yǎng)支持52例分析[J];吉林醫(yī)學(xué);2011年35期

，

本文編號：1958876